Warfarin Sodium tablets

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Approval Status:

Approved March 1997

Specific Treatments:

Anticoagulant, or "blood thinner" to keep blood clots from forming or getting larger

Therapeutic Areas

Find Related Trials for The Following Conditions

General Information

Seven strengths of Warfarin Sodium tablets, the generic equivalent of DuPont Merck’s anti-coagulant Coumadin, have been approved for marketing.